Clinical Trial Update: Impact of Hyperoncotic Albumin to Support Blood Loss Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial update on hyperoncotic albumin for supporting blood loss replacement; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss
• Fluid Retention

Drugs mentioned

• Hyperoncotic albumin (human serum albumin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Blood Loss, Surgical, Fluid Retention | Phase 4 | Status: COMPLETED